NCT02275923

Reveal LINQ™ Evaluation of Fluid

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 9 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the use of subcutaneous impedance measured with an implanted Medtronic Reveal LINQ™ insertable cardiac monitor for use as a fluid status monitor in hemodialysis patients. The study will measure the changes in subject subcutaneous impedance and compare with the fluid status assessed by the volume removed from the hemodialysis subject during dialysis sessions. Subcutaneous impedance trends will also be evaluated between dialysis sessions.

Conditions

• End Stage Renal Disease

Interventions

Type	Name	Description
DEVICE	Reveal LINQ™ Insertable Cardiac Monitor	Insertable cardiac monitor

Timeline

• Start date: 2014-10-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2014-10-27
• Last updated: 2019-04-05
• Results posted: 2019-04-05

Locations

1 site across 1 country: Australia